Peers of BioCardia Inc (BCDA)
Side-by-side comparison
Health Care · Biotechnology
Enterprise value divided by trailing twelve-month revenue. A capital-structure-neutral sales valuation metric.
Latest EV/Sales
3039.24x
As of Jun 27, 2025
Beyond EV/Sales, the valuation view includes forward multiples, EV ratios, cash flow yields, and multi-year chart history for further research.
| Date | EV/Sales |
|---|---|
| Jun 27, 2025 | 3039.24x |
| Jun 26, 2025 | 3164.10x |
| Jun 25, 2025 | 3195.32x |
| Jun 24, 2025 | 3086.07x |
| Jun 23, 2025 | 2836.35x |
| Jun 20, 2025 | 2929.99x |
| Jun 18, 2025 | 2992.42x |
| Jun 17, 2025 | 2976.81x |
EV/Sales = Enterprise Value / Revenue (TTM). Enterprise Value = Market Cap + Total Debt − (Cash & Short-Term Investments + Long-Term Investments).
EV/Sales is particularly useful in M&A analysis and for companies with significant debt.
Read the general EV/Sales definition, formula, and analyst usage guide.
EV/Sales guideInformational research only; not personalized advice. Values reflect the latest available data on Chartloom and may differ from other sources.
Side-by-side comparison